Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06506890Not ApplicableNot Yet Recruiting

Study to Determine the Difference in Reduction of Bioaerosols in a Long-term Care Facility

Role: collaborator

NCT03805906Completed

Ultrasound-guided L5 Dorsal Ramus Block

Role: collaborator

NCT03761043Not ApplicableCompleted

Nurse Promotion of IV to PO Antimicrobial Conversion

Role: lead

NCT01029782Phase 2Completed

Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis

Role: lead

All 4 trials loaded